Certified by Founder Lodge
Solarea Bio
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $15,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Solarea Bio is a clinical-stage biotechnology company in Cambridge, MA developing plant-based microbial solutions to some of the world’s largest health problems. Solarea was founded in 2017
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 09 ,2023 | Series B | $15,000,000 |
BOLD Capital Partners
S2G Ventures
Viking Global Investors
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
